These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1266 related items for PubMed ID: 19457126

  • 1. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK, Wong AK, Lee YW, Wan OW, Chan HY, Chung KK.
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [Abstract] [Full Text] [Related]

  • 2. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
    Chu Y, Dodiya H, Aebischer P, Olanow CW, Kordower JH.
    Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Selective loss of dopaminergic neurons and formation of Lewy body-like aggregations in alpha-synuclein transgenic fly neuronal cultures.
    Park SS, Lee D.
    Eur J Neurosci; 2006 Jun; 23(11):2908-14. PubMed ID: 16819979
    [Abstract] [Full Text] [Related]

  • 5. Heat shock proteins reduce alpha-synuclein aggregation induced by MPP+ in SK-N-SH cells.
    Fan GH, Zhou HY, Yang H, Chen SD.
    FEBS Lett; 2006 May 29; 580(13):3091-8. PubMed ID: 16678164
    [Abstract] [Full Text] [Related]

  • 6. Protein degradation, aggregation, and misfolding.
    Cuervo AM, Wong ES, Martinez-Vicente M.
    Mov Disord; 2010 May 29; 25 Suppl 1():S49-54. PubMed ID: 20187257
    [Abstract] [Full Text] [Related]

  • 7. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
    Maingay M, Romero-Ramos M, Carta M, Kirik D.
    Neurobiol Dis; 2006 Sep 29; 23(3):522-32. PubMed ID: 16806952
    [Abstract] [Full Text] [Related]

  • 8. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.
    Pan T, Kondo S, Le W, Jankovic J.
    Brain; 2008 Aug 29; 131(Pt 8):1969-78. PubMed ID: 18187492
    [Abstract] [Full Text] [Related]

  • 9. Ubiquitin-proteasome system and Parkinson's disease.
    Olanow CW, McNaught KS.
    Mov Disord; 2006 Nov 29; 21(11):1806-23. PubMed ID: 16972273
    [Abstract] [Full Text] [Related]

  • 10. Alpha-synuclein and autophagy as common steps in neurodegeneration.
    Ferrucci M, Pasquali L, Ruggieri S, Paparelli A, Fornai F.
    Parkinsonism Relat Disord; 2008 Nov 29; 14 Suppl 2():S180-4. PubMed ID: 18583174
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
    Mandel S, Grunblatt E, Riederer P, Amariglio N, Jacob-Hirsch J, Rechavi G, Youdim MB.
    Ann N Y Acad Sci; 2005 Aug 29; 1053():356-75. PubMed ID: 16179542
    [Abstract] [Full Text] [Related]

  • 15. A Drosophila model of Parkinson's disease.
    Feany MB, Bender WW.
    Nature; 2000 Mar 23; 404(6776):394-8. PubMed ID: 10746727
    [Abstract] [Full Text] [Related]

  • 16. Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement.
    Pan T, Kondo S, Zhu W, Xie W, Jankovic J, Le W.
    Neurobiol Dis; 2008 Oct 23; 32(1):16-25. PubMed ID: 18640276
    [Abstract] [Full Text] [Related]

  • 17. Intragastric proteasome inhibition induces alpha-synuclein-immunopositive aggregations in neurons in the dorsal motor nucleus of the vagus in rats.
    Miwa H, Kubo T, Suzuki A, Kondo T.
    Neurosci Lett; 2006 Jun 19; 401(1-2):146-9. PubMed ID: 16600504
    [Abstract] [Full Text] [Related]

  • 18. A pragmatic approach to biochemical systems theory applied to an alpha-synuclein-based model of Parkinson's disease.
    Sass MB, Lorenz AN, Green RL, Coleman RA.
    J Neurosci Methods; 2009 Apr 15; 178(2):366-77. PubMed ID: 19136028
    [Abstract] [Full Text] [Related]

  • 19. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage.
    Lev N, Melamed E, Offen D.
    Neurosci Lett; 2006 May 15; 399(1-2):27-32. PubMed ID: 16584840
    [Abstract] [Full Text] [Related]

  • 20. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N, Tanaka K.
    J Alzheimers Dis; 2010 May 15; 19(1):1-9. PubMed ID: 20061621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.